Skip to main content

Table 4 Pre- and post-surgery complications in mesh groups

From: Use of vaginal mesh for pelvic organ prolapse repair: a literature review

 

Randomized trials

Non randomized trials

Major bleeding

5.3%

1.23% (0–3.6)

8 patients out of 152 in 4 trials (1.6% to 13.8%) [9, 12, 17, 18]

29 trials n = 4164

Blood transfusion

3.1%

2.05% (0–25)

2 patients out of 63 in 2 trials (2.7% to 3.1%) [5, 19]

24 trials n = 3379

Haematoma

3%

2.15% (0–8.3)

4 patients out of 131 in 2 trials (3.8% to 9.5%) [5, 7]

41 trials n = 6034

Bladder injury

2.5%

1.94% (0–8.3)

4 patients out of 160 in 3 trials (0% to 9.6%) [6, 9, 19]

51 trials n = 6827

Ureteral injury

1 patients out of 31 in 1 trials [5]

1.55%

2 trials n = 359

Uretral injury

1 patients out of 29 in 1 trials [17]

1.6%

1 trial n = 123

Vaginal injury

0

4.35% (1.6–5.5)

2 trials n = 99

Rectal injury

0

0.58%

47 trials n = 5877

  1. NAS non-absorbable and synthetic, AS absorbable and synthetic